Contrast-induced nephropathy remains a serious complication of PCI.
Mehran
Roxana
R
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA.
D000111:Acetylcysteine / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D003287:Contrast Media / Q000009:adverse effects*; D018450:Disease Progression; D018818:Fenoldopam / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control; D011379:Prognosis; D012307:Risk Factors; D017693:Sodium Bicarbonate / Q000627:therapeutic use
D003287:Contrast Media; D017693:Sodium Bicarbonate; D018818:Fenoldopam; D000111:Acetylcysteine